netFormulary South East London Joint Medicines Formulary NHS
Guy's and St Thomas' NHS Foundation Trust
Kings College Hospital NHS Foundation Trust
Lewisham and Greenwich NHS Trust		  
 Search
 Formulary Chapter 2: Cardiovascular system - Full Chapter
Notes:

Where a formulary entry does not detail a medicine’s indications for use, the medicine can be assumed to be approved for all licensed indications.

Formulary approved "off-label" use is detailed separately.
Chapter Links...
Link   NICE NG106: Chronic heart failure in adults: diagnosis and management
Link   SE London APC guidance: optimising therapy in chronic stable angina
Link   SE London APC Guidance: Pharmacological management of Heart Failure
Link   SE London Area Prescribing Committee: General Principles of Heart Failure Management During COVID-19
 Details...
02.02.04  Expand sub section  Potassium-sparing diuretics with other diuretics
Co-amilofruse tabs (amiloride with furosemide)
View adult BNF View SPC online 		Formulary  
   
Co-amilozide tabs (amiloride with hydrochlorothiazide)
View adult BNF View SPC online 		Formulary  
Link  MHRA Nov 18: Hydrochlorothiazide: risk of non-melanoma skin cancer, particularly in long-term use
   
Co-triamterzide tabs (triamterine with hydrochlorothiazide)
View adult BNF View SPC online 		Formulary  
Link  MHRA Nov 18: Hydrochlorothiazide: risk of non-melanoma skin cancer, particularly in long-term use
   
Amiloride with cyclopenthiazide tabs (Navispare®)
View adult BNF View SPC online 		Formulary  
   
 ....
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
 Display tracking information
click to search medicines.org.uk
 Link to adult BNF
click to search medicines.org.uk
 Link to SPCs
SMC
 Scottish Medicines Consortium
Cytotoxic Drug
 Cytotoxic Drug
CD
 Controlled Drug
High Cost Medicine
 High Cost Medicine
Cancer Drugs Fund
 Cancer Drugs Fund
NHSE
 NHS England
Homecare
 Homecare
CCG
 CCG

Traffic Light Status Information

Status Description

Red

 Specialist or hospital prescribing only. The responsibility for prescribing, monitoring, dose adjustment and review should remain with the specialist or hospital. In very exceptional circumstances a specialist may discuss individual patient need for a RED drug to be prescribed by a GP and the GP should consider informing the Medicines Management team before a decision is made to prescribe for individual patients.   

Amber 1

 Treatment can be initiated in primary care after a recommendation from an appropriate specialist  

Amber 2

 Specialist initiation followed by maintenance prescribing in primary care  

Amber 3

 Specialist initiation with ongoing monitoring required. After dose stabilisation GPs can be requested to take over prescribing responsibilities using the approved APC shared care documentation  

Green

 Specialist and non-specialist initiation  

Grey

 Not recommended for prescribing  

netFormulary